<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01804816</url>
  </required_header>
  <id_info>
    <org_study_id>12-580</org_study_id>
    <nct_id>NCT01804816</nct_id>
  </id_info>
  <brief_title>Acupuncture on Cardiac and Autonomic Function in Human Heart Failure</brief_title>
  <official_title>Acupuncture on Cardiac and Autonomic Function in Human Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acupuncture treatment may improve the cardiac function and the quality of life in heart
      failure patients. These effects may be related to the inhibition of sympathetic activity
      and/or increased vagal function. The suppression of inflammatory reaction with acupuncture
      treatment may also be associated with these outcomes. Specific aims include:

        1. To evaluate the effect of acupuncture treatment on human cardiac sympathetic/vagal
           activity

        2. To evaluate the effect of acupuncture treatment on cardiac function and functional
           capacity

        3. To evaluate the general health score of the quality-of-life with acupuncture treatment

        4. To explore the mechanism of acupuncture treatment on inflammation and nitrative stress
           in heart failure patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary aim of this study is to evaluate the effect of acupuncture treatment on cardiac
      sympathetic/vagal activity in chronic heart failure patients. The investigators would like to
      investigate the effect of acupuncture treatment on cardiac function and the general health
      score of the quality-of-life. The investigators would like to further explore the mechanism
      of acupuncture treatment on autonomic imbalance and chronic inflammatory reaction in heart
      failure patients by comparing the treatment and sham groups, the baseline before the
      treatment and the changes after treatment.

      Chronic heart failure affects millions people and is a leading cause of death in US. Despite
      of advance in diagnoses and treatments, the long-term prognosis and quality of life of
      chronic heart failure patients remain poor. The mortality of chronic heart failure is
      estimated 50% within 4 years, and is more than 50% in patients with severe chronic heart
      failure.

      Chronic heart failure results from the left ventricular (LV) systolic and/or diastolic
      dysfunction. Autonomic imbalance with sustained sympathetic overdrive and vagal withdrawal
      plays an important role in the development of chronic heart failure. This autonomic
      dysregulation is related to increased heart rate, excess inflammatory response, progressive
      LV dysfunction, increased mortality and morbidity in chronic heart failure patients.
      Sympathetic active inhibition with beta-adrenergic receptor blockers has shown significant
      reduction in mortality and morbidity in chronic heart failure patients. Also modulation of
      parasympathetic activation with electrical vagus nerve stimulation (VNS) has demonstrated as
      a potential therapy for chronic heart failure.

      Acupuncture has been widely used in China for thousands of years to treat a variety of
      diseases and their symptoms. Except pain disorders, increasing evidences have shown that
      acupuncture may be useful for cardiovascular diseases, such as coronary artery disease,
      hypertension and chronic heart failure. It has been demonstrated that certain acupuncture
      points have shown to inhibit cardiac sympathetic activation or increase cardiac vagal
      component in both experimental animals and clinical studies. Recently a small clinical trial
      by Dr. Kristen, et al has found that acupuncture could improve exercise tolerance in chronic
      heart failure patients.

      The investigators hypothesize that acupuncture treatment may improve the cardiac function and
      the quality of life in heart failure patients. These effects may be related to the inhibition
      of sympathetic activity and/or increased vagal function. The suppression of inflammatory
      reaction with acupuncture treatment may also be associated with these outcomes. In addition
      to optimized standard heart failure medications, acupuncture may be a safe therapeutic
      strategy in chronic heart failure treatment. Studies of acupuncture on cardiac autonomic
      activity in heart failure may show more evidence of acupuncture treatment in chronic heart
      failure patients.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Cardiac Function: LVEF</measure>
    <time_frame>Baseline, Week 7, Week 13</time_frame>
    <description>Left ventricular ejection fraction (LVEF) percentage was measured at baseline, after 5 weeks of no treatment and just prior to acupuncture treatment, and after 5 weeks of acupuncture treatments.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in 6-Minute Walk Distance</measure>
    <time_frame>Baseline, Week 7, Week 13</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Quality of Life (QOL)</measure>
    <time_frame>Baseline, Week 7, Week 13</time_frame>
    <description>Patients quality of life (QOL) was assessed using the Kansas City Cardiomyopathy Questionnaire (KCCQ) at baseline, after 5 weeks of no treatment and just prior to acupuncture treatment, and after 5 weeks of acupuncture treatments. Scores reported here are the Quality of Life Scores, which range from 0 to 100. Higher numbers indicate a better quality of life.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Chronic Heart Failure</condition>
  <arm_group>
    <arm_group_label>Acupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 standardized verum acupuncture (VA) sessions twice a week, over 5 weeks. The 5 weeks of acupuncture were scheduled after the period of no acupuncture for each subject.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Acupuncture</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>No acupuncture treatment or other study intervention over 5 weeks. All subjects had a 5 week period of &quot;no acupuncture&quot; prior to the 5 weeks of acupuncture sessions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>Standardized acupuncture administration for 10 sessions.</description>
    <arm_group_label>Acupuncture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No Intervention</intervention_name>
    <description>No intervention during this period. This was a control period. Each subject acted as their own control.</description>
    <arm_group_label>No Acupuncture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 21 years

          -  Congestive Heart Failure (CHF), New York Heart Association (NYHA) class II-III, LVEF
             ≤40%

          -  All patients will have sinus rhythm and compensate with individually optimized
             standard heart failure medications. Routine medications will be continued during the
             study period

          -  Able and willing to give informed consent or comply with study procedures.

        Exclusion Criteria:

          -  Acupuncture treatment within 3 months before the beginning of the study

          -  Presents with cutaneous eczema at potential acupoints

          -  Have a history of major bleeding or increased propensity of excessive bleeding due to
             platelet dysfunction

          -  Currently taking anti-coagulants (e.g. warfarin)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>W.H. Wilson Tang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yanming Huang, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Middlekauff HR, Hui K, Yu JL, Hamilton MA, Fonarow GC, Moriguchi J, Maclellan WR, Hage A. Acupuncture inhibits sympathetic activation during mental stress in advanced heart failure patients. J Card Fail. 2002 Dec;8(6):399-406.</citation>
    <PMID>12528093</PMID>
  </reference>
  <reference>
    <citation>Kurono Y, Minagawa M, Ishigami T, Yamada A, Kakamu T, Hayano J. Acupuncture to Danzhong but not to Zhongting increases the cardiac vagal component of heart rate variability. Auton Neurosci. 2011 Apr 26;161(1-2):116-20. doi: 10.1016/j.autneu.2010.12.003. Epub 2011 Jan 7.</citation>
    <PMID>21216208</PMID>
  </reference>
  <reference>
    <citation>Deng YJ, Liang WX, Cheng SY. [Influence of acupoint-catgut-implantation on blood pressure and cardiac function in chronic congestive heart failure rats]. Zhen Ci Yan Jiu. 2011 Feb;36(1):40-5. Chinese.</citation>
    <PMID>21585058</PMID>
  </reference>
  <reference>
    <citation>Kristen AV, Schuhmacher B, Strych K, Lossnitzer D, Friederich HC, Hilbel T, Haass M, Katus HA, Schneider A, Streitberger KM, Backs J. Acupuncture improves exercise tolerance of patients with heart failure: a placebo-controlled pilot study. Heart. 2010 Sep;96(17):1396-400. doi: 10.1136/hrt.2009.187930. Epub 2010 Jun 15.</citation>
    <PMID>20554511</PMID>
  </reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>March 4, 2013</study_first_submitted>
  <study_first_submitted_qc>March 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2013</study_first_posted>
  <results_first_submitted>June 5, 2018</results_first_submitted>
  <results_first_submitted_qc>December 21, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">March 29, 2019</results_first_posted>
  <last_update_submitted>January 21, 2020</last_update_submitted>
  <last_update_submitted_qc>January 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Wilson Tang</investigator_full_name>
    <investigator_title>Staff Cellular and Molecular Medicine and Cardiovascular Medicine</investigator_title>
  </responsible_party>
  <keyword>Chronic Heart Failure</keyword>
  <keyword>Heart Failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to make individual patient data available.</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited from the Cleveland Clinic Heart and Vascular Institute section of Heart Failure and Transplant Medicine.</recruitment_details>
      <pre_assignment_details>All subjects acted as their own controls for this study and were assigned to a 5 week period of no acupuncture or other study interventions (control) followed by a 5 week period of weekly standardized verum acupuncture (intervention).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>No Acupuncture / Acupuncture</title>
          <description>5 weeks of no treatment followed by 5 weeks of standardized verum acupuncture.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>No Acupuncture (Initial 5 Weeks)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Acupuncture (Second 5 Weeks)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>No Acupuncture/Acupuncture</title>
          <description>No Acupuncture: No treatment. Baseline period. Acupuncture: Standardized acupuncture administration for 10 sessions using acupuncture needles.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.9" spread="9.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Cardiac Function: LVEF</title>
        <description>Left ventricular ejection fraction (LVEF) percentage was measured at baseline, after 5 weeks of no treatment and just prior to acupuncture treatment, and after 5 weeks of acupuncture treatments.</description>
        <time_frame>Baseline, Week 7, Week 13</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Baseline</title>
            <description>Measurements at baseline visit.</description>
          </group>
          <group group_id="O2">
            <title>Pre-Acupuncture</title>
            <description>Measurements were taken after 5 full weeks of no treatment. This visit occurred 6-7 weeks after the baseline measurements.</description>
          </group>
          <group group_id="O3">
            <title>Post-Acupuncture</title>
            <description>Measurements were taken after 10 sessions of standardized verum acupuncture administration using 0.18-0.25×30-60-mm stainless steel needles. Acupuncture sessions were scheduled twice a week for 5 weeks. This post-acupuncture visit occurred within 1 week of finishing the acupuncture sessions.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Cardiac Function: LVEF</title>
          <description>Left ventricular ejection fraction (LVEF) percentage was measured at baseline, after 5 weeks of no treatment and just prior to acupuncture treatment, and after 5 weeks of acupuncture treatments.</description>
          <units>LVEF Percentage</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.14" spread="7.23"/>
                    <measurement group_id="O2" value="36.11" spread="8.97"/>
                    <measurement group_id="O3" value="40.59" spread="9.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>a=0.05</non_inferiority_desc>
            <p_value>0.063</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in 6-Minute Walk Distance</title>
        <time_frame>Baseline, Week 7, Week 13</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Baseline</title>
            <description>Measurements at baseline visit</description>
          </group>
          <group group_id="O2">
            <title>Pre-Acupuncture</title>
            <description>Measurements were taken after 5 full weeks of no treatment. This visit occurred 6-7 weeks after the baseline measurements.</description>
          </group>
          <group group_id="O3">
            <title>Post-Acupuncture</title>
            <description>Measurements were taken after 10 sessions of standardized verum acupuncture administration using 0.18-0.25×30-60-mm stainless steel needles. Acupuncture sessions were scheduled twice a week for 5 weeks. This post-acupuncture visit occurred within 1 week of finishing the acupuncture sessions.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in 6-Minute Walk Distance</title>
          <units>Feet</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1376.2" spread="250.19"/>
                    <measurement group_id="O2" value="1488.0" spread="264.82"/>
                    <measurement group_id="O3" value="1515.10" spread="268.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Based on results from prior small clinical trials we estimate the need for 20 patients enrolled to reach 80% statistical power.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>a = 0.05</non_inferiority_desc>
            <p_value>0.005</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>a=0.05</non_inferiority_desc>
            <p_value>0.002</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>a=0.05</non_inferiority_desc>
            <p_value>0.441</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Quality of Life (QOL)</title>
        <description>Patients quality of life (QOL) was assessed using the Kansas City Cardiomyopathy Questionnaire (KCCQ) at baseline, after 5 weeks of no treatment and just prior to acupuncture treatment, and after 5 weeks of acupuncture treatments. Scores reported here are the Quality of Life Scores, which range from 0 to 100. Higher numbers indicate a better quality of life.</description>
        <time_frame>Baseline, Week 7, Week 13</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Baseline</title>
            <description>Measurements at baseline visit</description>
          </group>
          <group group_id="O2">
            <title>Pre-Acupuncture</title>
            <description>Measurements were taken after 5 full weeks of no treatment. This visit occurred 6-7 weeks after the baseline measurements.</description>
          </group>
          <group group_id="O3">
            <title>Post-Acupuncture</title>
            <description>Measurements were taken after 10 sessions of standardized verum acupuncture administration using 0.18-0.25×30-60-mm stainless steel needles. Acupuncture sessions were scheduled twice a week for 5 weeks. This post-acupuncture visit occurred within 1 week of finishing the acupuncture sessions.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Quality of Life (QOL)</title>
          <description>Patients quality of life (QOL) was assessed using the Kansas City Cardiomyopathy Questionnaire (KCCQ) at baseline, after 5 weeks of no treatment and just prior to acupuncture treatment, and after 5 weeks of acupuncture treatments. Scores reported here are the Quality of Life Scores, which range from 0 to 100. Higher numbers indicate a better quality of life.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.00" spread="26.59"/>
                    <measurement group_id="O2" value="67.50" spread="24.36"/>
                    <measurement group_id="O3" value="69.17" spread="25.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>a=0.05</non_inferiority_desc>
            <p_value>0.729</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>10 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>No Acupuncture/Acupuncture</title>
          <description>No Acupuncture: No treatment. Baseline period. Acupuncture: Standardized acupuncture administration for 10 sessions using acupuncture needles.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization</sub_title>
                <description>Subjects were hospitalized for worsening heart failure, which was not unanticipated since a diagnosis of heart failure and a decreased left ventricular ejection fraction were required for study inclusion. Hospitalizations were subject-reported.</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>These results should be interpreted with caution. With only 10 subjects, the study may be under-powered to detect a significant difference.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. W.H. Wilson Tang, MD</name_or_title>
      <organization>Cleveland Clinic Foundation</organization>
      <phone>(216) 444-2121</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

